Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
- 1 July 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (13), 4299-4311
- https://doi.org/10.1158/1078-0432.ccr-08-1883
Abstract
Purpose: Cancer stem cells represent an attractive therapeutic target for tumor eradication. The present study aimed to determine whether CD133 expression may identify cells with characteristics of cancer stem/progenitor cells in human endometrial tumors.Keywords
Other Versions
This publication has 55 references indexed in Scilit:
- CD133-Expressing Stem Cells Associated with Ovarian Metastases Establish an Endothelial Hierarchy and Contribute to Tumor VasculatureThe International Journal of Cell Cloning, 2009
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsCancer Research, 2008
- Is CD133 a marker of metastatic colon cancer stem cells?JCI Insight, 2008
- CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumorsJCI Insight, 2008
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006
- ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant MelanomaCancer Research, 2005
- At the root of brain cancerNature, 2004
- Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cellsTransfusion, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997